{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:12:27Z","timestamp":1790838747940,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier","isbn-type":[{"value":"9780443222443","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.mcb.2025.02.006","type":"book-chapter","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:33:06Z","timestamp":1741797186000},"page":"81-114","source":"Crossref","is-referenced-by-count":7,"title":["Modeling neurodegeneration and neuroinflammation in Parkinson\u2019s Disease: Animal-based strategies"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.mcb.2025.02.006_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152297","article-title":"Neuroprotective and anti-inflammatory effects of linoleic acid in models of Parkinson\u2019s Disease: The implication of lipid droplets and lipophagy","author":"Alarcon-Gil","year":"2022","journal-title":"Cells"},{"key":"10.1016\/bs.mcb.2025.02.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2006.04.011","article-title":"Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra","author":"Arimoto","year":"2007","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.mcb.2025.02.006_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1175-8","article-title":"Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson\u2019s disease","author":"Bao","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.mcb.2025.02.006_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nbt870","article-title":"Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice","author":"Barberi","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(20)30302-1","article-title":"Parkinson\u2019s disease as a preventable pandemic","author":"Barker","year":"2020","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson\u2019s disease","author":"Beal","year":"2001","journal-title":"Nature Review Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib7","doi-asserted-by":"crossref","DOI":"10.2741\/S415","article-title":"Parkinson\u2019s disease: A review","author":"Beitz","year":"2014","journal-title":"Frontiers in Bioscience-Scholar"},{"key":"10.1016\/bs.mcb.2025.02.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/0361-9230(91)90242-C","article-title":"Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats","author":"Berger","year":"1991","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.mcb.2025.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson\u2019s disease","author":"Betarbet","year":"2002","journal-title":"Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib10","article-title":"Microglia mediated dopaminergic cell death in the substantia nigra: A new animal model for Parkinson\u2032s disease","author":"Bing G","year":"1998","journal-title":"Neuroscience Abstracts"},{"key":"10.1016\/bs.mcb.2025.02.006_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","author":"Blum-Degen","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.mcb.2025.02.006_bib12","article-title":"Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism","author":"Bonito-Oliva","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2009.11.020","article-title":"Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson\u2019s disease","author":"Branchi","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib14","doi-asserted-by":"crossref","DOI":"10.1159\/000080983","article-title":"Caenorhabditis elegans MPP+ model of Parkinson\u2019s disease for high-throughput drug screenings","author":"Braungart","year":"2004","journal-title":"Neuro-Degenerative Diseases"},{"key":"10.1016\/bs.mcb.2025.02.006_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1564-7","article-title":"The endotoxin hypothesis of neurodegeneration","author":"Brown","year":"2019","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.mcb.2025.02.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(86)91316-8","article-title":"The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting","author":"Brundin","year":"1986","journal-title":"Brain Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2004.02.026","article-title":"Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background","author":"Cabin","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.mcb.2025.02.006_bib18","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","author":"Casta\u00f1o","year":"1998","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00089","article-title":"Caenorhabditis elegans: A model to investigate oxidative stress and metal dyshomeostasis in Parkinson\u2019s disease","author":"Chege","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010012","article-title":"Galangin reduces the loss of dopaminergic neurons in an LPS-evoked model of Parkinson\u2019s disease in rats","author":"Chen","year":"2017","journal-title":"International Journal of Molecular Science"},{"key":"10.1016\/bs.mcb.2025.02.006_bib21","article-title":"Exercise ameliorates motor deficits and improves dopaminergic functions in the rat hemi-parkinson\u2019s model","author":"Chen","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.mcb.2025.02.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","author":"Chiueh","year":"1984","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005482","article-title":"Striatal neuroinflammation promotes Parkinsonism in rats","author":"Choi","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.006_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice","author":"Clark","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.006_bib25","doi-asserted-by":"crossref","DOI":"10.3791\/1376","article-title":"Rehen Murine model for Parkinson\u2019s disease: From 6-OH dopamine lesion to behavioral test","author":"da Concei\u00e7\u00e3o","year":"2010","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/bs.mcb.2025.02.006_bib26","article-title":"Characterization of graded 6-hydroxydopamine unilateral lesion in medial forebrain bundle of mice","author":"Cui","year":"2024","journal-title":"Scientific Report"},{"key":"10.1016\/bs.mcb.2025.02.006_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-4-34","article-title":"Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons","author":"Daher","year":"2009","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.mcb.2025.02.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson\u2019s disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","author":"Dauer","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.006_bib30","doi-asserted-by":"crossref","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway","author":"Deumens","year":"2002","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-alpha and IL-6 with ageing and Parkinsonism","author":"Dobbs","year":"1999","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/bs.mcb.2025.02.006_bib32","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","author":"Dorsey","year":"2018","journal-title":"Journal of Parkinsons Diseases"},{"key":"10.1016\/bs.mcb.2025.02.006_bib33","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.247965","article-title":"E46K human alpha-synuclein transgenic mice develop lewy-like and tau pathology associated with age-dependent, detrimental motor impairment","author":"Emmer","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13618","article-title":"Cellular models for Parkinson\u2019s disease","author":"Falkenburger","year":"2016","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/0014-4886(69)90081-8","article-title":"Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra","author":"Faull","year":"1969","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-014-0230-3","article-title":"Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson\u2019s disease models are mediated by GPR109A-dependent mechanisms","author":"Fu","year":"2015","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.mcb.2025.02.006_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","author":"Giasson","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.mcb.2025.02.006_bib38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.006_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2010.07265.x","article-title":"Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson\u2019s disease","author":"Grealish","year":"2010","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009944","article-title":"Drosophila as a model to study mitochondrial dysfunction in Parkinson\u2019s disease","author":"Guo","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/bs.mcb.2025.02.006_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-016-1392-6","article-title":"Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide","author":"He","year":"2016","journal-title":"BMC Complementary Alternative Medicine"},{"key":"10.1016\/bs.mcb.2025.02.006_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: Mendelian vs. non-Mendelian inheritance","author":"Hernandez","year":"2016","journal-title":"Journal of Neurochemisty"},{"key":"10.1016\/bs.mcb.2025.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2007.05148.x","article-title":"Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide","author":"Hern\u00e1ndez-Romero","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib44","doi-asserted-by":"crossref","DOI":"10.1006\/nbdi.2000.0289","article-title":"The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system","author":"Herrera","year":"2000","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.mcb.2025.02.006_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2011.11.027","article-title":"Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites","author":"Heuer","year":"2012","journal-title":"Behavioral Brain Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","author":"Hinkle","year":"2012","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.mcb.2025.02.006_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: A target for neuroprotection?","author":"Hirsch","year":"2009","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/00001756-200203040-00006","article-title":"Behavior, neurochemistry and histology after intranigral lipopolysaccharide injection","author":"Hsieh","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/bs.mcb.2025.02.006_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","author":"Hunter","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib50","article-title":"Fenbendazole treatment may influence lipopolysaccharide effects in rat brain","author":"Hunter","year":"2007","journal-title":"Comparative Medicine"},{"key":"10.1016\/bs.mcb.2025.02.006_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.22012","article-title":"Intrastriatal lipopolysaccharide injection induces parkinsonism in C57\/B6 mice","author":"Hunter","year":"2009","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2016.09.007","article-title":"Lipopolysaccharide-induced functional and structural injury of the mitochondria in the nigrostriatal pathway","author":"Hunter","year":"2017","journal-title":"Neuroscience Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Paul behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice","author":"Iancu","year":"2005","journal-title":"Behavioural Brain Research"},{"issue":"2","key":"10.1016\/bs.mcb.2025.02.006_bib54","doi-asserted-by":"crossref","DOI":"10.1006\/neur.1995.0016","article-title":"6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/bs.mcb.2025.02.006_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2009.11.015","article-title":"Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies","author":"Koob","year":"2010","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","author":"Koprich","year":"2017","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-007-0862-4","article-title":"Spatial deficits in a mouse model of Parkinson disease","author":"De Leonibus","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2025.02.006_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","author":"Lee","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.006_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/bs.mcb.2025.02.006_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(00)00033-6","article-title":"Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats","author":"Lu","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1339716","article-title":"Age and gender differences in non-motor symptoms in people with Parkinson\u2019s disease","author":"Maas","year":"2024","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-017-1772-1","article-title":"Parkinson\u2019s disease pathogenesis from the viewpoint of small fish models","author":"Matsui","year":"2018","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/bs.mcb.2025.02.006_bib65","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: A new look at an old problem","author":"Meredith","year":"2006","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.mcb.2025.02.006_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/S0892-0362(98)00037-3","article-title":"MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study","author":"Mikkelsen","year":"1999","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","author":"Mogi","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.mcb.2025.02.006_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2017.07.013","article-title":"Characterization of a presymptomatic stage in a Drosophila Parkinson\u2019s disease model: Unveiling dopaminergic compensatory mechanisms","author":"Molina-Mateo","year":"2017","journal-title":"Biochimica et Biophysica Acta. Molecular Basis of Disease"},{"key":"10.1016\/bs.mcb.2025.02.006_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017240","article-title":"Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease","author":"Morales-Garc\u00eda","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.006_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.10.008","article-title":"Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice","author":"Morales-Garc\u00eda","year":"2015","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.mcb.2025.02.006_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-019-01745-z","article-title":"Phosphodiesterase 7 regulation in cellular and rodent models of Parkinson\u2019s Disease","author":"Morales-Garcia","year":"2020","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib73","doi-asserted-by":"crossref","unstructured":"Morales-Garcia, J. A., et al. (2017). CCAAT\/Enhancerbinding protein \u03b2 silencing mitigates glial activation and neurodegeneration ina rat model of Parkinson\u2019s disease. Scientific Reports.","DOI":"10.1038\/s41598-017-13269-4"},{"key":"10.1016\/bs.mcb.2025.02.006_bib74","article-title":"Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson\u2019s disease","author":"M\u00fcller","year":"1998","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/bs.mcb.2025.02.006_bib75","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-017-1722-y","article-title":"Non-human primate models of PD to test novel therapies","author":"Morissette","year":"2018","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/bs.mcb.2025.02.006_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2016.12.008","article-title":"Gender effect on non-motor symptoms in Parkinson\u2019s disease: Are men more at risk?","author":"Nicoletti","year":"2017","journal-title":"Parkinsonism Related Disorders"},{"key":"10.1016\/bs.mcb.2025.02.006_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.995","article-title":"Mouse and rat anesthesia and analgesia","author":"Oh","year":"2024","journal-title":"Current Protocols"},{"issue":"7","key":"10.1016\/bs.mcb.2025.02.006_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: Mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.mcb.2025.02.006_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncl.2022.12.001","article-title":"Sex and gender differences in Parkinson\u2019s disease","author":"Patel","year":"2023","journal-title":"Neurologic Clinics"},{"key":"10.1016\/bs.mcb.2025.02.006_bib80","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/bs.mcb.2025.02.006_bib81","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/bs.mcb.2025.02.006_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson\u2019s disease","author":"Przedborski","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.mcb.2025.02.006_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014020","article-title":"Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy implications for excitotoxicity","volume":"5","author":"Price","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/bs.mcb.2025.02.006_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0404.2007.00894.x","article-title":"Circulating interleukin-15 and RANTES chemokine in Parkinson\u2019s disease","author":"Rentzos","year":"2007","journal-title":"Acta Physiologica Scandinavica. Supplementum"},{"key":"10.1016\/bs.mcb.2025.02.006_bib86","doi-asserted-by":"crossref","DOI":"10.1006\/exnr.2002.7882","article-title":"Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice","author":"Richfield","year":"2002","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.006_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib89","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.2003.01929.x","article-title":"Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: Role of inducible nitric oxide synthase and protection by indomethacin","author":"Shibata","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib90","article-title":"Absence of inclusion body formation in the MPTP mouse model of Parkinson\u2019s disease","author":"Shimoji","year":"2005","journal-title":"Brain"},{"key":"10.1016\/bs.mcb.2025.02.006_bib91","article-title":"Mechanism of the neurotoxicity of MPTP. An update","author":"Singer","year":"1990","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.mcb.2025.02.006_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-Induced model of neuroinflammation: Mechanisms of action, research application and future directions for its use","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/bs.mcb.2025.02.006_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46576-0","article-title":"Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson\u2019s disease","author":"Sl\u00e9zia","year":"2023","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.mcb.2025.02.006_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","author":"Smaji\u0107","year":"2022","journal-title":"Brain"},{"key":"10.1016\/bs.mcb.2025.02.006_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","author":"Steinmetz","year":"2024","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.12459","article-title":"Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson\u2019s disease","author":"Stott","year":"2014","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/bs.mcb.2025.02.006_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention","author":"Tansey","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","author":"Tansey","year":"2022","journal-title":"Nature Review Immunology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","author":"Tong","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.006_bib100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","author":"Tong","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.006_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27505","article-title":"Underrepresentation of women in Parkinson\u2019s disease trials","author":"Tosserams","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.mcb.2025.02.006_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(69)90122-X","article-title":"Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat","author":"Ungerstedt","year":"1969","journal-title":"Brain Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","author":"Ungerstedt","year":"1970","journal-title":"Brain Research"},{"key":"10.1016\/bs.mcb.2025.02.006_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","article-title":"Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/bs.mcb.2025.02.006_bib105","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/bs.mcb.2025.02.006_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030719","article-title":"Novel approaches for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease","author":"Van Bulck","year":"2019","journal-title":"International Journal of Molecular Science"},{"key":"10.1016\/bs.mcb.2025.02.006_bib107","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","author":"Vila","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mcb.2025.02.006_bib108","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","author":"Vila","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.006_bib109","article-title":"Parkinson\u2019s disease: Autoimmunity and neuroinflammation","author":"Virgilio","year":"2016","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/bs.mcb.2025.02.006_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/0028-3908(73)90061-0","article-title":"Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: Effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants","author":"Von Voigtlander","year":"1973","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.mcb.2025.02.006_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2015.09.013","article-title":"Biochanin a protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson\u2019s disease","author":"Wang","year":"2015","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.mcb.2025.02.006_bib112","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","author":"Ye","year":"2023","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10.1016\/bs.mcb.2025.02.006_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290317","article-title":"Reversal of pathological motor behavior in a model of Parkinson\u2019s disease by striatal dopamine uncaging","author":"Zamora-Ursulo","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.006_bib114","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-023-02846-2","article-title":"Lipopolysaccharide-binding protein and future Parkinson\u2019s disease risk: A European prospective cohort","author":"Zhao","year":"2023","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.mcb.2025.02.006_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-014-1744-7","article-title":"Generation of CRISPR\/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer","author":"Zhou","year":"2015","journal-title":"Cellular and Molecular Life Sciences: CMLS"}],"container-title":["Methods in Cell Biology","Animal Models of Disease - Part D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:49:32Z","timestamp":1757364572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X25000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443222443"],"references-count":115,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2025.02.006","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}